Arkolith/Insider Trading/CMPI/Form 4

Fuhrman Alan

DirectorCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed May 31, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 31, 2022Disposed to issuer(D)10K——0
May 31, 2022Disposed to issuer(D)247K——0
May 31, 2022Disposed to issuer(D)23K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-020078) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML